Crown Laboratories will acquire StriVectin and StriVectin’s products will become part of Crown’s new premium skincare division. StriVectin will operate as a wholly owned subsidiary of Crown Laboratories as StriVectin’s president, Cori Aleardi, will become president and chief commercial officer of Crown. “Partnering with StriVectin is an exciting and significant next step in diversifying and scaling our organization,” says Jeff Bedard, Crown Laboratories CEO. “StriVectin has assembled a truly impressive team, a proven business model, and a premier product portfolio that is beloved by its customers. We are particularly excited that Cori will be assuming a senior executive role at Crown, helping to guide the merged businesses, and we think the combined talents of both teams will enable us to accelerate growth across all our product areas. The addition of StriVectin to Crown’s portfolio enriches our focus on partnering with our customers throughout their lifetime skin health journey.”
Related Articles
Crown Aesthetics Partners with Cosmetic Skin & Surgery Center
Crown Aesthetics Announces New Indication For SkinPen Precision
Crown Aesthetics Announces Class IIa CE Certification